Alcedis GmbH stands for long years of CRO experience and profound expertise in the conduct of clinical trials. One focal point distinguishing Alcedis is our innovative software systems constitute a centrepiece of the Alcedis trademark.
Our module-based service concept adjusts itself flexibly to your project structure. Likewise individually adapted are our data entry and software systems.
With our network of qualified partners, we conduct national or international phase I to IV multi-center studies, non-interventional studies and registers for medicinal products and medical devices.
2. August 2018 - European Melanoma Registry (EuMelaReg)
Capture of real-world data of treating melanoma patients across Europe The collection and evaluation of real-world data is of particular importance for the further development of treatment strategies, clinical guidelines and future innovation for prevention, diagnosis and treatment of cancer. In approval studies the application of study medication is recorded...
e2b (R3) -Let’s think beyond...
For years electronic exchange of ICSRs with the EudraVigilance database in an e2b-compliant standard has become mandatory for all MAHs of medicinal products. However, ICSRs from the CRO’s clinical database to the MAHs in both, non-interventional studies and clinical trials, are still transmitted paper-based or in electronic portable document format (pdf). The benefits of using ...
January 4, 2018 - Christmas fundraising game raises 3602€!
As our favourite Christmas tradition at Alcedis this year´s fundraising game was quite a challenge of skill and patience. A tiny ball had to be skillfully navigated through a tricky maze where the Alcedo bird marked the successful game at the finishing line. We thank all participants and gladly forward the donations and your kind Christmas greetings to the non-profit organization...
(Deutsch) 1. September 2017 - Digitale Innovation in der klinischen Forschung: Beispiele der praktischen Anwendung
Das Trendwort Digitalisierung ist allgegenwärtig und prägt auch das klinische Studiengeschäft. Der klassische Papierfragebogen ist fast vollends dem web-basierten eCRF gewichen, doch ist das längst nicht alles. Die elektronische Erfassung und die Lieferanten von Studiendaten sind mannigfaltig. Betrachten wir zunächst die sogenannten Wearables. Wir kennen viele davon aus dem alltägl...
May 18, 2017 - Alcedis CEO Michael Lorsbach participates in B20 Germany, 2017
As a part of the G20 process to strengthen economic growth, the B20 Health Initiative has been launched to ensure an exchange platform for the actors in global health to drive innovative health systems. The B20 Health Conference will be held the 18th of May under the headline: Resilient Health Systems Shaping the Future of Health Care Together. An important theme at the conference ...
Years of Experience
Lines software code
Partner and References
Our clients and partner are at home all over this globe. Check out a choice of references.